Skip to main content
. 2020 May 8;295(27):9121–9133. doi: 10.1074/jbc.RA120.012659

Figure 6.

Figure 6.

SK1-A decreases sphingoid base accumulation in NPC1KO cells. A, SphK1 and S1P lyase enzymatic activity in WT and NPC1KO CHO cells was measured and normalized to total protein. B, lipids were extracted from WT, NPC1KO, and NPC1KI CHO cells, and sphingosine and dihydrosphingosine were measured by LC-ESI-MS/MS. C and D, NPC1KO CHO cells were treated without or with SK1-A (10 μm) for 24 h. *, p < 0.05 compared with WT; #, p < 0.05 compared with NPC1KO. C, in vivo SphK activity was determined by LC-ESI-MS/MS quantification of conversion of C17-sphingosine (1 μm) to C17-S1P after 30 min and normalized to total lipid phosphates. *, p < 0.05 compared with WT. D, sphingosine and dihydrosphingosine were measured by LC-ESI-MS/MS. All data are means ± S.D. (error bars) and representative of three independent experiments, each with three biological replicates. *, p < 0.05 compared with WT; #, p < 0.05 compared with NPC1KO. p values were determined by two-tailed Student's t test (A) or one-way ANOVA followed by Tukey's post hoc analysis (B–D).